Genmab A/S (GMAB)
26.33
-0.71
(-2.63%)
USD |
NASDAQ |
May 29, 16:00
26.34
+0.02
(+0.06%)
Pre-Market: 20:00
Genmab Price : 26.33 for May 29, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 224.11 |
| Zealand Pharma A/S | 48.74 |
| Bavarian Nordic A/S | 9.66 |
| Evaxion AS | 4.00 |
| Johnson & Johnson | 225.33 |
Price Related Metrics
| PE Ratio | 19.85 |
| PS Ratio | 4.286 |
| Price to Book Value | 2.854 |
| Price to Free Cash Flow | 19.15 |
| Earnings Yield | 5.04% |
| Market Cap | 16.22B |
| Operating PE Ratio | 12.99 |
| Normalized PE Ratio | 16.79 |